Market News

First Light Asset Management Boosted Its Healthstream (HSTM) Holding by $303,577; Merck & Co (MRK) Shareholder Essex Investment Management Co Cut Stake by $686,336 as Shares Declined

Essex Investment Management Co Llc decreased its stake in Merck & Co Inc (MRK) by 50.58% based on its latest 2017Q3 regulatory filing with the SEC. Essex Investment Management Co Llc sold 10,724 shares as the company’s stock declined 2.46% while stock markets rallied. The hedge fund held 10,478 shares of the health care company at the end of 2017Q3, valued at $671,000, down from 21,202 at the end of the previous reported quarter. Essex Investment Management Co Llc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $159.82 billion market cap company. The stock increased 1.84% or $1.06 during the last trading session, reaching $58.66. About 12.34M shares traded or 0.58% up from the average. Merck & Co., Inc. (NYSE:MRK) has risen 16.86% since January 14, 2017 and is uptrending. It has outperformed by 0.16% the S&P500.

First Light Asset Management Llc increased its stake in Healthstream Inc (HSTM) by 7.09% based on its latest 2017Q3 regulatory filing with the SEC. First Light Asset Management Llc bought 13,199 shares as the company’s stock rose 23.08% with the market. The institutional investor held 199,243 shares of the technology company at the end of 2017Q3, valued at $4.66 million, up from 186,044 at the end of the previous reported quarter. First Light Asset Management Llc who had been investing in Healthstream Inc for a number of months, seems to be bullish on the $774.12 million market cap company. The stock decreased 0.53% or $0.13 during the last trading session, reaching $24.27. About 86,216 shares traded. HealthStream, Inc. (NASDAQ:HSTM) has risen 29.68% since January 14, 2017 and is uptrending. It has outperformed by 12.98% the S&P500.

Investors sentiment decreased to 1.06 in 2017 Q3. Its down 0.01, from 1.07 in 2017Q2. It dived, as 46 investors sold MRK shares while 619 reduced holdings. 106 funds opened positions while 598 raised stakes. 1.96 billion shares or 0.47% more from 1.95 billion shares in 2017Q2 were reported. Raymond James & Assocs holds 0.68% of its portfolio in Merck & Co., Inc. (NYSE:MRK) for 5.27 million shares. Bkd Wealth Advisors Lc has 19,644 shares for 0.14% of their portfolio. Motco has invested 0.36% in Merck & Co., Inc. (NYSE:MRK). Wesbanco Bancshares has invested 1.35% in Merck & Co., Inc. (NYSE:MRK). Deroy And Devereaux Private Counsel Inc has 1.8% invested in Merck & Co., Inc. (NYSE:MRK). Texas-based Rench Wealth Mgmt has invested 1.58% in Merck & Co., Inc. (NYSE:MRK). The Illinois-based Envestnet Asset has invested 0.1% in Merck & Co., Inc. (NYSE:MRK). Windsor Cap Management has invested 0.27% in Merck & Co., Inc. (NYSE:MRK). B And T Cap Mngmt Dba Alpha Cap Mngmt has invested 1.17% in Merck & Co., Inc. (NYSE:MRK). Kings Point Management stated it has 0.87% in Merck & Co., Inc. (NYSE:MRK). Ls Investment Ltd has 81,518 shares. Bluemountain Cap Ltd Limited Liability Company has 0.1% invested in Merck & Co., Inc. (NYSE:MRK) for 79,040 shares. Enterprise Fincl stated it has 20,009 shares. Brandywine Glob Invest Mngmt Limited Co stated it has 0.97% in Merck & Co., Inc. (NYSE:MRK). Salem Counselors Inc stated it has 1.24% in Merck & Co., Inc. (NYSE:MRK).

Essex Investment Management Co Llc, which manages about $740.27 million and $735.81 million US Long portfolio, upped its stake in Harvard Bioscience Inc (NASDAQ:HBIO) by 111,359 shares to 540,819 shares, valued at $2.03M in 2017Q3, according to the filing. It also increased its holding in Boeing Co (NYSE:BA) by 3,147 shares in the quarter, for a total of 10,716 shares, and has risen its stake in Amicus Therapeutics Inc (NASDAQ:FOLD).

Analysts await Merck & Co., Inc. (NYSE:MRK) to report earnings on February, 1. They expect $0.94 earnings per share, up 5.62% or $0.05 from last year’s $0.89 per share. MRK’s profit will be $2.56B for 15.60 P/E if the $0.94 EPS becomes a reality. After $1.11 actual earnings per share reported by Merck & Co., Inc. for the previous quarter, Wall Street now forecasts -15.32% negative EPS growth.

Among 23 analysts covering Merck & Co. Inc. (NYSE:MRK), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Merck & Co. Inc. had 71 analyst reports since August 13, 2015 according to SRatingsIntel. The company was maintained on Friday, July 28 by SunTrust. The firm has “Hold” rating given on Thursday, August 27 by Berenberg. The firm has “Buy” rating given on Friday, January 13 by Bryan Garnier & Cie. The stock has “Hold” rating by Societe Generale on Wednesday, September 30. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Piper Jaffray on Friday, July 28. The stock has “Overweight” rating by Piper Jaffray on Thursday, January 12. The stock of Merck & Co., Inc. (NYSE:MRK) has “Buy” rating given on Tuesday, November 24 by Berenberg. Jefferies maintained Merck & Co., Inc. (NYSE:MRK) rating on Thursday, July 14. Jefferies has “Hold” rating and $53 target. The firm has “Overweight” rating by Barclays Capital given on Friday, September 9. The rating was maintained by BMO Capital Markets with “Buy” on Friday, July 28.

Among 10 analysts covering Healthstream (NASDAQ:HSTM), 4 have Buy rating, 0 Sell and 6 Hold. Therefore 40% are positive. Healthstream had 23 analyst reports since July 22, 2015 according to SRatingsIntel. As per Monday, October 23, the company rating was maintained by Needham. On Friday, October 6 the stock rating was maintained by Canaccord Genuity with “Hold”. The rating was maintained by Cantor Fitzgerald with “Hold” on Monday, June 26. The rating was downgraded by First Analysis to “Underweight” on Monday, January 23. The rating was maintained by Robert W. Baird with “Buy” on Thursday, August 31. Raymond James initiated the stock with “Market Perform” rating in Monday, August 3 report. The rating was initiated by Sidoti with “Neutral” on Wednesday, December 30. The stock of HealthStream, Inc. (NASDAQ:HSTM) earned “Hold” rating by Needham on Wednesday, October 25. The firm earned “Equal-Weight” rating on Wednesday, July 27 by First Analysis. The stock of HealthStream, Inc. (NASDAQ:HSTM) earned “Hold” rating by Cantor Fitzgerald on Monday, October 23.

Investors sentiment increased to 1.61 in Q3 2017. Its up 0.07, from 1.54 in 2017Q2. It is positive, as 14 investors sold HSTM shares while 27 reduced holdings. 22 funds opened positions while 44 raised stakes. 23.41 million shares or 3.05% less from 24.14 million shares in 2017Q2 were reported. Ny State Teachers Retirement Systems holds 0% in HealthStream, Inc. (NASDAQ:HSTM) or 10,523 shares. Emerald Mutual Fund Advisers reported 241,472 shares. Rhumbline Advisers accumulated 0% or 48,864 shares. Ftb Advsrs holds 0% or 248 shares. Sector Pension Invest Board stated it has 16,159 shares. Great West Life Assurance Can has invested 0% in HealthStream, Inc. (NASDAQ:HSTM). Tci Wealth Advisors Inc owns 22 shares. Renaissance Limited Liability Corp invested 0% of its portfolio in HealthStream, Inc. (NASDAQ:HSTM). Moreover, Qs Investors Ltd Llc has 0% invested in HealthStream, Inc. (NASDAQ:HSTM) for 27 shares. Greenleaf reported 981 shares or 0% of all its holdings. Thomson Horstmann And Bryant has 303,815 shares. Moreover, Stephens Mngmt Ltd Liability Corporation has 0.31% invested in HealthStream, Inc. (NASDAQ:HSTM). Pinebridge Invests Lp invested in 3,166 shares or 0% of the stock. D E Shaw Communications Inc holds 0% or 60,407 shares. Swiss Bancorporation has invested 0% in HealthStream, Inc. (NASDAQ:HSTM).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *